Interleukin-6 Antagonist [EPC]

649 reported adverse events

Drugs of this class: SILTUXIMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 140
1 DRUG INEFFECTIVE 98
2 CYTOKINE RELEASE SYNDROME 60
3 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 47
4 HYPERTENSION 44
5 DISEASE PROGRESSION 40
6 DEATH 37
7 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33
8 CATARACT 32
9 HEPATIC STEATOSIS 31
See all common reactions for Interleukin-6 Antagonist [EPC]

Drugs of the Interleukin-6 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BCG RELATED CYSTITIS 8 0.4000
1 SHORT STATURE 30 0.1145
2 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 19 0.1092
3 SPINAL INSTABILITY 25 0.0984
4 ATLANTOAXIAL INSTABILITY 9 0.0811
5 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 8 0.0530
6 CYSTITIS VIRAL 7 0.0183
7 HUMAN HERPESVIRUS 6 ENCEPHALITIS 5 0.0176
8 RELAPSING FEVER 5 0.0173
9 STEATOHEPATITIS 7 0.0131
See all enriched reactions for Interleukin-6 Antagonist [EPC]